-The Times of India NEW DELHI: Various drug price regulatory measures by the government helped consumers save Rs 4,988 crore over the last two years, Rajya Sabha was told on Thursday. Following approval of the pharmaceutical pricing policy in 2012, the government has capped prices of essential medicines at least three times since 2013, when the policy was first implemented by the National Pharmaceutical Pricing Authority through the Drugs Price Control Order...

-The Indian Express New FDI policy in food products is unlikely to be a game-changer by itself. Government must clear up the policy environment. n a rather bold move on June 20, the Modi government opened several key sectors such as defence, pharmaceuticals, civil aviation and food products to 100 per cent foreign direct investment (FDI). The objective behind this FDI policy is to attract higher investments, better technologies in manufacturing, commerce,...

-PTI Prices of 42 essential medicines used in treatment of various ailments including tuberculosis, cancer, cardiac diseases, asthma, epilepsy and depression have been capped by the government, reducing their cost by up to 15 per cent. Drug price regulator, National Pharmaceutical Pricing Authority (NPPA), in a notification on its website, said it “has fixed/revised ceiling prices of 45 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016.” “Out of the 45,...

-The Hindu The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. Humanitarian aid organisation Médecins Sans Frontières (MSF) has warned India that the country will not remain ‘pharmacy of the developing world’ if the proposals in the Regional Comprehensive Economic Partnership agreement (RCEP) are adopted. The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. MSF Access Campaign...

-PTI India will need to front load its investments substantially to almost double the number of people on ARV treatment in less than five years, Minister for Health and Family Welfare, J P Nadda said at UNGA. United Nations: With over 80 per cent of the affordable and quality anti-retroviral drugs used globally to treat AIDS supplied by Indian pharmaceutical industry, India has sought flexibilities in IPR under a global trade...